Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

One of Europe’s leading VCs banks a €725M ‘crossover’ fund

Sofinnova Partners, which has backed the likes of successful drugmakers such as Abivax, Argenx and Verona Pharma, will use the cash to support a new group of later-stage biotechs.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Monday 16 November →